Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
about
Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPaseSemaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeletonGuidance molecules in lung cancerA Dual Binding Mode for RhoGTPases in Plexin SignallingA cytosolic juxtamembrane interface modulates plexin A3 oligomerization and signal transduction.Loss of plexin-B3 in hepatocellular carcinoma.Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis.Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.The role of semaphorins and their receptors in gliomasPlexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.Reviewing the somatic genetics of melanoma: from current to future analytical approaches.Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.Neat1 is a p53-inducible lincRNA essential for transformation suppression.The neural guidance receptor Plexin C1 delays melanoma progression.Function of mutant and wild-type plexinb1 in prostate cancer cells.The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
P2860
Q24294818-DC93FAA3-20D8-4B4B-8F90-102A4D5F9BFBQ24307909-067F3E39-DA7C-4B31-9001-D7E4331E7F86Q24598659-B208D9C5-10B6-4CB1-AA0B-AC73D98BAA4CQ27673776-43CF1140-89A4-4508-8B2A-03858468D448Q34856542-0098A7C6-8B0D-44D1-B0AF-BF1C0520CB40Q35159658-F3176C71-59D8-4E99-A49F-ADF48C14E416Q35550099-C5C8059A-AE8B-41B5-9EE6-258BD2B34961Q35663729-1555D219-2B6C-4FCC-8C76-6B432F04D40AQ35952075-03305040-9106-4D64-8609-5C97EC96016FQ36289377-07BE47B3-3444-4E45-8804-EE495630438AQ36852674-6BEEC7E9-DF2D-4F1F-A3D5-0B7EEC00D83BQ37327493-81E7F945-130B-4030-90F0-664436D132EDQ37976140-A8B46818-DFEC-4D1F-AC7F-6F3A9B4217C4Q38022543-B3D3169B-5DE9-4403-BD08-E52B7C9B1E83Q38683437-03061945-021E-4A3E-9F50-C8740DE1DC07Q39243225-BFA0567E-60DF-4AB1-A669-465022DF87D6Q43088887-1658792E-FF9C-4DE8-BAA1-7C19F1AB0C08Q55405777-A6115EA8-B75F-4813-B295-D7562C22CA55
P2860
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
@en
type
label
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
@en
prefLabel
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
@en
P2093
Antonio Marchetti
Asha Balakrishnan
Carlo Zanon
Fonnet E Bleeker
Junia Y Penachioni
Lara Felicioni
Simona Lamba
P2860
P304
P356
10.1002/HUMU.21017
P50
P577
2009-08-01T00:00:00Z